National Institute of Oncology, Budapest, Hungary
Profile
Orcid
🎓 Early Academic Pursuits
Prof. Dr. Zsuzsanna Suba embarked on her academic journey at the Semmelweis University of Medicine, earning her Doctor of Medicine in 1971. Her early interest in both general and oral pathology led her to pursue multiple certifications: Board certification in Pathology (1975), Dentistry and Stomatology (1986), and Oral Pathology (Sheffield, UK, 1987). She further advanced her academic credentials by completing a Ph.D. in 1994 and attaining the Habilitated Medical Science (Habil.Med.Sci.) degree in 2004, marking her as a leading expert in her field.
🩺 Professional Endeavors
Prof. Suba's career commenced in 1971 as an Assistant Professor at the 1st Institute of Pathology and Experimental Cancer Research at her alma mater. She then led the Oral Pathology Division within the Department of Oral and Maxillofacial Surgery at Semmelweis University from 1982 to 2011. In 2004, she was officially named Professor of Oral Pathology. Her final academic post was at the National Institute of Oncology, where she served as Professor of Pathology from 2011 until becoming Professor Emeritus in 2017, reflecting her decades-long contribution to academic medicine.
🧬 Contributions and Research Focus
Prof. Suba’s research has significantly shaped understanding in several niche yet vital domains of pathology. Her early work investigated cell proliferation kinetics and virus-induced experimental tumors. She later pioneered studies into the pathology of bone replacement in the oral and maxillofacial region, and the clinical and pathological evaluation of chemotherapy outcomes in oral cancers. Notably, she explored the correlations between metabolic disorders (like type-2 diabetes, insulin resistance, and obesity) and cancer incidence, particularly oral and breast cancers. Her groundbreaking research highlighted the hormonal mechanisms involved in tumor progression, the role of estrogen signaling in cancer risk, and even proposed a genome-stabilizing therapeutic model for breast cancer cases.
🌍 Impact and Influence
Prof. Suba’s research has had a substantial impact on the epidemiological and hormonal understanding of cancer biology, especially in women’s health. Her bold interpretations of the paradoxes in antiestrogen treatments in breast cancer, and her promotion of causal therapy over symptomatic treatment, have sparked meaningful discourse in oncological and hormonal therapy communities. Her findings bridge molecular biology, pathology, endocrinology, and clinical practice, positioning her as a multidisciplinary influencer in medical science.
📈 Academic Citations and Publications
With 128 peer-reviewed articles accumulating a total impact factor of 122.647, Prof. Suba has maintained a strong presence in the scientific literature. She has authored 12 books, 42 book chapters—many in English—and accumulated 1,230 independent citations as a first or last author. These achievements speak volumes about the relevance and longevity of her scientific contributions.
🖥️ Technical and Research Skills
Her academic career has been deeply rooted in molecular and surgical pathology techniques, including histopathological diagnostics, tumor cell kinetic analysis, and clinical trials of chemotherapy and hormone therapy outcomes. Her interdisciplinary acumen allows her to integrate pathology, biochemistry, endocrinology, and epidemiology in both laboratory and clinical research contexts.
👩🏫 Teaching Experience and Recognition
A beloved educator, Prof. Suba has been honored multiple times for her teaching excellence. She received the Teacher’s Award from Semmelweis University (1998) and again in 2008, this time chosen directly by students. She is known for her dedicated mentorship, ability to simplify complex medical content, and commitment to fostering critical thinking in future clinicians and researchers.
🏅 Honors and Awards
Throughout her illustrious career, she has been decorated with prestigious awards such as the MOTESZ Award for Young Researchers (1976), the Markusovszky Award (1993), and the recent Distinguished Cancer Treatment Innovation Award (2024) from Scifax. These accolades recognize both her innovative research and her lifelong dedication to cancer pathology.
🌟 Legacy and Future Contributions
Now serving as Professor Emeritus, Prof. Suba remains a venerated figure in oncology and pathology. Her visionary work on hormonal and metabolic links to cancer continues to guide current investigations. Her legacy lies not only in her scientific outputs but also in the inspired careers of countless students and clinicians she mentored. Her genome-stabilization framework offers a promising direction for personalized cancer therapy, and future researchers will undoubtedly build upon her foundational insights for decades to come.
Selected Publications
-
Suba Zsuzsanna (2024)
DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care
Cancers (Basel), 16(8):1573. April 19, 2024.
-
Suba Zsuzsanna (2024)
Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus‑Faced Manner
Current Oncology, 31(9):4885–4907. August 24, 2024.
-
Suba Zsuzsanna (2023)
Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens
Oncology Reviews, 17:10708 (eCollection). April 19, 2023.
-
Suba Zsuzsanna (2020)
Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen‑Responsive Cancer Cells via Activating Mutations
Journal of Oncology & Therapy (or equivalent publication). 2020.
-
Suba Zsuzsanna (2018)
Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors
Recent Patents on Anticancer Drug Discovery, 13(4):428–444. 2018.